142 related articles for article (PubMed ID: 38058668)
1. Cervical Cytology and Histology Correlation as an Analytic Quality Assurance Exercise: Experience from an Accredited Cytology Laboratory.
Belekar SV; Kamal M; Warke AS
J Cytol; 2023; 40(4):205-210. PubMed ID: 38058668
[TBL] [Abstract][Full Text] [Related]
2. Quality metrics in cervical cytopathology: A single institutional study.
Senthil Kumar D; Ravikumar G
Cytopathology; 2022 Mar; 33(2):230-235. PubMed ID: 34854153
[TBL] [Abstract][Full Text] [Related]
3. Patients with epithelial cell abnormality in PAP smears: correlation of results with follow-up smears and cervical biopsies.
Türkmen IÇ; Başsüllü N; Korkmaz P; Günenç B; Baykal CM; Güdücü N; Işçı H; Dünder I; Doğusoy GB
Turk Patoloji Derg; 2013; 29(3):179-84. PubMed ID: 24022307
[TBL] [Abstract][Full Text] [Related]
4. "See and treat" approach is appropriate in women with high-grade lesions on either cervical cytology or colposcopy.
Aue-Aungkul A; Punyawatanasin S; Natprathan A; Srisomboon J; Kietpeerakool C
Asian Pac J Cancer Prev; 2011; 12(7):1723-6. PubMed ID: 22126552
[TBL] [Abstract][Full Text] [Related]
5. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests.
Elsheikh TM; Kirkpatrick JL; Wu HH
Cancer; 2006 Oct; 108(5):277-81. PubMed ID: 16937376
[TBL] [Abstract][Full Text] [Related]
6. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
7. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear.
Gothwal M; Nalwa A; Singh P; Yadav G; Bhati M; Samriya N
J Obstet Gynaecol India; 2021 Feb; 71(1):72-77. PubMed ID: 33814802
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of Abnormal Cervical Lesions and its Cytohistological Correlation: a Study from an Institute of National Importance of Western Rajasthan.
Gothwal M; Singh P; Elhence P; Yadav G; Sharma C; Samriya N
Maedica (Bucur); 2022 Sep; 17(3):636-640. PubMed ID: 36540604
[No Abstract] [Full Text] [Related]
9. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
11. Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions.
Kim SI; Kim SJ; Suh DH; Kim K; No JH; Kim YB
J Gynecol Oncol; 2020 Mar; 31(2):e13. PubMed ID: 31912671
[TBL] [Abstract][Full Text] [Related]
12. Outcome of "Atypical Squamous Cells" in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure.
Song JS; Hwang I; Gong G
Korean J Pathol; 2012 Aug; 46(4):359-64. PubMed ID: 23110028
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Cytonucleomorphometric Parameters for Cases Diagnosed as Squamous Cell Abnormality on Conventional Cervico-Vaginal Pap Smears.
Mishra S; Khurana U; Kapoor N; Joshi A; Joshi D
J Cytol; 2023; 40(1):5-11. PubMed ID: 37179967
[TBL] [Abstract][Full Text] [Related]
14. Low-grade pap smears containing occasional high-grade cells as a predictor of high-grade dysplasia.
Power P; Gregoire J; Duggan M; Nation J
J Obstet Gynaecol Can; 2006 Oct; 28(10):884-887. PubMed ID: 17140504
[TBL] [Abstract][Full Text] [Related]
15. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
16. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
17. Histopathological discrepancies between colposcopy-directed biopsy and LEEP-conization observed during SARS-CoV-2 pandemic.
Pruski D; Przybylski M; Millert-Kalinska S; Zmaczynski A; Jach R
Ginekol Pol; 2023; 94(1):12-18. PubMed ID: 36043301
[TBL] [Abstract][Full Text] [Related]
18. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
Zhao C; Zhao S; Heider A; Austin RM
Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Differences between Bethesda Groups according to Conventional Smear and Liquid-Based Cytology Methods in Cervicovaginal Cytology: A Single-Center Experience with 165,915 Cases.
Ucak R; Dilbaz OF; Polat N
Acta Cytol; 2024; 68(1):54-59. PubMed ID: 38320537
[TBL] [Abstract][Full Text] [Related]
20. Improved abnormal Pap smear triage using cervical cancer biomarkers.
Killeen JL; Dye T; Grace C; Hiraoka M
J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
